Algert Global’s Tenaya Therapeutics TNYA Stock Holding History

Algert Global’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,030	Closed	-$64K	–	1338
2024 Q3	$64K	Buy	33,030 +9,193	+39%	+$26K	﹤0.01%	1139
2024 Q2	$74K	Buy	+23,837	New	+$98.4K	﹤0.01%	1425

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Algert Global's TNYA Position: Q4 2024 in Review

Algert Global sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 33,030 shares — an estimated $64K sold.

Algert Global first reported a position in TNYA in Q2 2024 and held it in 2 quarters. The position peaked at $74K in Q2 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

Algert Global reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
Algert Global sold 33,030 Tenaya Therapeutics shares in Q4 2024, an estimated $64K.
Algert Global first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 2 quarters.
Algert Global's Tenaya Therapeutics position peaked at $74K in Q2 2024.
88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.